CS logo
small CS logo
Moritz Kaposi General Hospital

Kaposvar, Hungary
Hospital in Kaposvár
Kaposvár, Tallián Gyula u 20-32, 7400

About Moritz Kaposi General Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
CTI BioPharma
1
Terumo Europe N.V.
1
Total Rows: 2

Clinical Trials at Moritz Kaposi General Hospital


During the past decade, Moritz Kaposi General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
2011-04-20
2018-09-14
Completed
312
Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry
2014-06-01
2020-06-01
Unknown status
37,000

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsCTI BioPharma: 1CTI BioPharma: 1Terumo Europe N.V.: 1Terumo Europe N.V.: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Moritz Kaposi General Hospital


According to Clinical.Site data, the most researched conditions in "Moritz Kaposi General Hospital" are "Coronary Artery Disease" (1 trials), "DLBCL Transformed From Indolent Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Grade 3 Lymphoma" (1 trials) and "de Novo DLBCL" (1 trials). Many other conditions were trialed in "Moritz Kaposi General Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Moritz Kaposi General Hospital


Most popular intervention types in "Moritz Kaposi General Hospital" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine + Rituximab" (1 trials) and "Pixantrone + Rituximab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Moritz Kaposi General Hospital


The vast majority of trials in "Moritz Kaposi General Hospital" are 2 trials for "All" genders.

Clinical Trials Status at Moritz Kaposi General Hospital


Currently, there are NaN active trials in "Moritz Kaposi General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Moritz Kaposi General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Moritz Kaposi General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Unknown status: 1Unknown status: 1